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Macrophages undergo metabolic rewiring during polarization but details of this process are unclear. In this
issue of Immunity, Jha et al. (2015) report a systems approach for unbiased analysis of cellular metabolism
that reveals key metabolites and metabolic pathways required for distinct macrophage polarization states.Technological advances in metabolomics
are being brought to bear on the immune
response. Striking findings are being
made that provide new insights intometa-
bolic processes occurring inside immune
cells—insights that have consequences
for cellular phenotypes (O’Neill and Har-
die, 2013; Ganeshan and Chawla, 2014).
Notable examples include enhanced
glycolysis (the so-called Warburg Effect)
being a feature of inflammatory cells,
such as M1 macrophages and CD4+ T
helper 17 (Th17) lymphocytes. Cells that
participate more in immunoregulation or
the resolution of inflammation, such as
M2 macrophages or regulatory T cells,
have fatty acid oxidation and an intact
Krebs cycle as hallmark metabolic fea-
tures. It is still not fully understood why
these differences occur, or indeed how
the metabolic rewiring is regulated.
Rapidity of response might be an
important reason for the metabolic differ-
ences (Ganeshan and Chawla, 2014). In
M1 macrophages, glycolysis would allow
for rapid ATP production to fuel activation
in acute inflammation or anti-bacterial
defense, whereas in M2 macrophages
oxidative phosphorylation occurs in the
more long-term process of resolution
and repair or in anti-parasitic immunity.
Jha et al. (2015) now provide us with the
most detailed account yet of metabolic
changes in macrophage polarization,
and they combine metabolomics with
transcriptomics to reveal distinct modules
in M1 and M2 macrophages. In M2 mac-
rophages, they uncover a module leading
to the metabolite UDP-GlcNAc, which is
needed for N-glycosylation. In M1 macro-
phages, two breaks are evident in the
Krebs cycle (such that in M1 macro-
phages it is not a cycle at all but instead
is fragmented). One break occurs at isoci-
trate dehydrogenase (IDH) and the other
after succinate, with a novel variant of apathway (termed the aspartate-argino-
succinate shunt) being evident. The me-
tabolites accumulating are shown to be
important for various functions of M1
and M2 macrophages, providing yet
more compelling evidence for the impor-
tance of immunometabolism in immunity
and inflammation.
To better understand the integration of
metabolomic changes and changes in
the transcriptome, the authors carried
out a non-targeted systems-level analysis
of transcriptional and metabolic changes
in the macrophage polarization process.
Remarkably, the authors obtained data
on more than 2,000 distinct metabolites
by mass spectrometry and, by using
systems-based algorithms, uncovered
modules specific for M2 and M1 macro-
phages. In M2 macrophages, increased
amino-sugar and nucleotide sugar me-
tabolites were evident, characterized by
high amounts of UDP-N-acetyl-alpha-D-
glucosamine (UDP-GlcNAc) and a corre-
sponding increase in enzymes producing
these metabolites. This result was consis-
tent with previous studies demonstrating
that highly glycosylated lectin/mannose
receptors are markers for M2 macro-
phages (Sica and Mantovani, 2012). The
functional consequence of elevated
UDP-GlcNAc and ensuing protein glyco-
sylation was demonstrated using inhibi-
tors of N-glycosylation that decreased
the expression of several M2 markers,
notably CD206 and CD301. The second
metabolic feature uncovered was in-
creased glutamine metabolism. An intact
Krebs cycle was evident, with a third of
all carbons in the Krebs cycle intermedi-
ates coming from glutamine. Half of the
nitrogen in UDP-GlcNAc was also shown
to come from glutamine. Deprivation of
glutamine inhibited M2 polarization, with
the chemokine CCL22, which is another
marker of M2 macrophages, being espe-Immunity 4cially glutamine dependent, although the
mechanistic link was not elucidated.
In M1 macrophages, a very different
metabolomics profile was observed. First,
two breaks were evident in the Krebs
cycle. The expression of the enzyme
isocitrate dehydrogenase, which con-
verts citrate to alpha-ketoglutarate, was
decreased 7-fold relative to M0 macro-
phages. This led to a build-up in citrate,
which was redirected for the production
of itaconic acid. This metabolite has
been shown to have anti-microbial prop-
erties (Michelucci et al., 2013). Citrate
will also be withdrawn for fatty acid
biosynthesis, another hallmark of the M1
macrophage. The second break-point in
the Krebs cycle occurred after succinate.
In the Krebs cycle, succinate is converted
to fumarate, which is then converted
to malate. A moderate accumulation in
succinate was observed, consistent with
previous studies (Tannahill et al., 2013).
However, a large increase in malate was
observed, indicating that the conversion
of succinate to fumarate was inefficient.
The increase in malate was explained by
an enhanced arginosuccinate shunt,
which fed into fumarate and then malate
production and also generated nitric
oxide by interfacing with the NO cycle.
Inhibition of aspartate aminotransferase,
a key enzyme in the shunt, suppressed
NO production and also interleukin-6
(IL-6) production, attesting to the impor-
tance of the arginosuccinate shunt for
M1 macrophage function.
This intellectually challenging and
detailed analysis of metabolic changes
occurring in macrophage polarization
therefore provides us with some impor-
tant new insights that are functionally
relevant (Figure 1). In M2 macrophages,
UDP-GlcNAc, required for protein glyco-
sylation, is enhanced. If this process is
inhibited, a decrease in expression of2, March 17, 2015 ª2015 Elsevier Inc. 393
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Figure 1. Metabolic Modules in M2 and M1 Macrophages Link to Function
Metabolic modules in M2 and M1 macrophages have been uncovered by a combined metabolomics-
transcriptional systems approach. Top: In M2 macrophages, there is an intact Krebs cycle replenished
from glutamine and glucose. UDP-GlcNAc accumulates, leading to enhanced protein glycosylation,
including the lectin/mannose receptor, which senses pathogens. Bottom: InM1macrophages, two breaks
occur in the Krebs cycle, leading to citrate accumulation, which is needed for anti-microbial itaconic acid
production and fatty acid synthesis with inflammatory consequences via prostaglandins. The second
break occurs after succinate (which activates HIF1-a, inducing inflammatory gene expression), with the
arginosuccinate shunt replenishing fumarate and malate for citrate production. The shunt also contributes
to NO production, for host defense and inflammation.
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how GlcNAc concentrations link to such
expression was not elucidated. The
authors speculate that N-glycosylation
might be needed to correctly fold and
traffic proteins such as CD206 and
CD301. Other receptors characteristic
of M2 macrophages, such as lectin/
mannose receptors, are heavily glycosy-
lated and presumably rely on elevated
GlcNAc. For M1 macrophages, two
breaks in the Krebs cycle are evident, at
IDH and succinate dehydrogenase. The
IDH break allows for citrate accumulation,
leading to fatty acid synthesis (which in394 Immunity 42, March 17, 2015 ª2015 Elseturn participates in such responses as
prostaglandin production) and can also
feed into NO production (Infantino et al.,
2011). Citrate also leads to the produc-
tion of the anti-microbial metabolite
itaconate, which has been shown to
inhibit the glyoxylate shunt pathway in
pathogens (e.g., in M. tuberculosis) but
not mammalian cells (Michelucci et al.,
2013). The break at IDH is therefore
critical for several functions of M1 macro-
phages. The second break occurs after
succinate, which can be withdrawn to
activate hypoxia inducible factor 1-alpha
(HIF1alpha), leading to increased expres-vier Inc.sion of HIF1alpha genes (Tannahill et al.,
2013). In addition, however, there is
induction of the arginosuccinate shunt,
which will ultimately replenish citrate.
Instead of replenishing citrate via a normal
Krebs cycle, the M1 macrophage uses
the arginosuccinate shunt because of
the break after succinate. In fact, if Krebs
himself had been using M1 macrophages
in his experiments, he would have found
a broken cycle. This study, along with
several others in the area of immuno-
metabolism, is therefore providing new
knowledge onmetabolic pathways, which
importantly link directly to the specific
functioning of immune cells. The paper is
being published as a Resource, allowing
others to mine the extensive data to
generate additional clues into metabolic
control of macrophage polarization.
Further work is likely to reveal even more
insights, which will hopefully lead to
improved understanding of immunity in
health and disease, which might prove
useful in the clinic.
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